Nagi Bioscience

Recent Finacing

Series A

Recent Raise

$13.5M

Nagi Bioscience develops Organism-on-Chip microfluidic lab platforms using C. elegans, sells the SydLab One system, and collaborates with pharma, chemical, cosmetic, agro, and biotech partners for testing and R&D.

Founded 2019

Vaud, Switzerland

11-50

Private

nagibio.ch

Highlights

Focus Areas

Biotechnology

Recent Investors

Z

Financials

$15.3M

Total Raised

2

Funding rounds

7

Investors

Team

Upgrade to view the team

See the team members at Nagi Bioscience.